Capstone Therapeutics will seek to create shareholder value through development of safe and effective therapeutic agents that serve unmet medical needs.
The Company will leverage its scientific knowledge to advance - independently and through alliances or partnership arrangements - commercially-viable product candidates in dermal scar reduction, pulmonary fibrosis and other forms of tissue fibrosis.